Zydus Wellness

Zydus Wellness EBITDA per Share

The EBITDA per Share of Zydus Wellness (ZYDUSWELL.NS) as of Nov 12, 2026 is 11.19 INR. In the previous year, EBITDA per Share was 12.55 INR — a change of -10.85% (lower).

EBITDA per Share

11.19INR

YoY

-10.85%

Last updated:

EBITDA per Share of Zydus Wellness is 2026 11.19 INR. EBITDA per Share of Zydus Wellness was 2025 12.55 INR. It decreases by -10.85% lower compared to the previous year.

The Zydus Wellness EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
31.74 INR
Jan 1, 2020
49.74 INR
Jan 1, 2021
53.98 INR
Jan 1, 2022
54.24 INR
Jan 1, 2023
56.25 INR
Jan 1, 2024
48.62 INR
Jan 1, 2025
12.55 INR
Jan 1, 2026
11.19 INR
The Zydus Wellness EBITDA per Share history
YEAREBITDA per ShareYoY
11.19INR-10.85%
12.55INR-74.19%
48.62INR-13.57%
56.25INR+3.70%
54.24INR+0.49%
53.98INR+8.52%
49.74INR+56.71%
31.74INR-0.95%
32.04INR+26.25%
25.38INR+8.70%
23.35INR-8.89%
25.63INR+11.53%
22.98INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zydus Wellness Stock analysis

What does Zydus Wellness do? Zydus Wellness Ltd. generates revenue through its integrated consumer business model, offering a diverse portfolio of health and wellness products. The company develops, produces, and distributes brands including Complan, a health food drink for growing children with milk protein and nutrients, and Sugar Free, a low-calorie sweetener for diabetics and weight watchers. Glucon-D, a glucose powder with Vitamin D and C in various flavors, and Everyuth Naturals, a skincare line, contribute to the product mix. Nycil, known for prickly heat powder, also expands into hand sanitizers, targeting health-conscious consumers and specific demographic segments such as children and diabetics. The company's revenue streams are driven by direct sales of its branded products to consumers across various segments. Complan targets school children and their parents, while Sugar Free appeals to calorie-conscious individuals and diabetics. Glucon-D serves those seeking quick energy with added vitamins, and Everyuth Naturals caters to skincare needs. Nycil's expansion into hand sanitizers broadens its appeal to health-focused consumers seeking hygiene solutions. Zydus Wellness Ltd. leverages its full value chain integration to efficiently manage production and distribution, ensuring product availability across its target markets. The brands are positioned to meet specific consumer needs, with Complan focusing on child nutrition, Sugar Free on sugar alternatives, Glucon-D on energy and vitamins, and Everyuth on skincare. Nycil's portfolio diversification into hand sanitizers reflects a strategic move to capture additional market segments within the wellness industry. Zydus Wellness is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zydus Wellness stock

EBITDA per Share of Zydus Wellness is 11.19 INR in 2026.

EBITDA per Share of Zydus Wellness changed from 12.55 INR to 11.19 INR, representing a -10.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Zydus Wellness since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Zydus Wellness

All Key Metrics — Zydus Wellness